ZA955032B - Treatment of nicotine craving and/or smoking withdrawal symptoms - Google Patents

Treatment of nicotine craving and/or smoking withdrawal symptoms

Info

Publication number
ZA955032B
ZA955032B ZA955032A ZA955032A ZA955032B ZA 955032 B ZA955032 B ZA 955032B ZA 955032 A ZA955032 A ZA 955032A ZA 955032 A ZA955032 A ZA 955032A ZA 955032 B ZA955032 B ZA 955032B
Authority
ZA
South Africa
Prior art keywords
treatment
withdrawal symptoms
nicotine craving
smoking withdrawal
smoking
Prior art date
Application number
ZA955032A
Other languages
English (en)
Inventor
Satyanarayana Majeti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA955032B publication Critical patent/ZA955032B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA955032A 1994-06-23 1995-06-19 Treatment of nicotine craving and/or smoking withdrawal symptoms ZA955032B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26426294A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
ZA955032B true ZA955032B (en) 1996-03-11

Family

ID=23005260

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955032A ZA955032B (en) 1994-06-23 1995-06-19 Treatment of nicotine craving and/or smoking withdrawal symptoms

Country Status (6)

Country Link
AU (1) AU2703695A (fr)
IL (1) IL114129A0 (fr)
MA (1) MA23588A1 (fr)
PE (1) PE33396A1 (fr)
WO (1) WO1996000071A1 (fr)
ZA (1) ZA955032B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20110053988A1 (en) * 2009-08-29 2011-03-03 Jorge Alberto Cassara Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke
DE102011114094A1 (de) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulierendes und belebendes Nasenspray und Nasentropfen
MX2018012439A (es) * 2016-04-12 2019-02-21 Solis Herrera Arturo Composiciones y metodos para el tratamiento de enfermedades de la mucosa nasal y paranasal con agonistas del receptor de acetilcolina de tipo nicotinico.
WO2019200427A1 (fr) * 2018-04-16 2019-10-24 Barista Mist Pty Ltd Compositions de caféine et procédés d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
PE33396A1 (es) 1996-08-19
WO1996000071A1 (fr) 1996-01-04
MA23588A1 (fr) 1995-12-31
AU2703695A (en) 1996-01-19
IL114129A0 (en) 1995-10-31

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
ZA955031B (en) Treatment of nicotine craving and/or smoking withdrawal symptoms
EP0713655A3 (fr) Succédané de cigarette et son procédé de fabrication
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
ZA886339B (en) Smoking article wrapper and method of making same
ZA886603B (en) Cigarette filter rods and cigarettes incorporating such filter rods
ZA955032B (en) Treatment of nicotine craving and/or smoking withdrawal symptoms
EP0632968A3 (fr) Cordon filtrant et son procédé de fabrication ainsi qu'un filtre pour fumée de tabac et son procédé de fabrication.
GB9306107D0 (en) Method of and machine for waking filters for tobacco smoke
ZA955033B (en) Treatment of nicotine craving and/or smoking withdrawal symptoms
HUP9904294A3 (en) Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain
GB9410482D0 (en) Tobacco smokers' mouthpiece
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
EP0443452A3 (en) One-side roughened rolled plane body and production thereof
ZA959717B (en) Tobacco rod and/or filter for smoking article
Bosman Acute effects of transdermal nicotine on EEG and mood during short-term smoking deprivation.
EP0696055A3 (fr) Assemblages électroniques et procédés de traitement
AU607214C (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
IL110749A0 (en) Smoker's device for reducing the consumption of cigarettes
GB2256573B (en) Method of storing cigarettes or cigars
NO942611D0 (no) Anvendelse av nikotin og innretning for inhalering av nikotin
GB9510439D0 (en) Smoking article and filter therefor
GB9325247D0 (en) Smokers'ashtray